BioSpace News Archive

Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing a new class of synthetic anti-infectives, is pleased to announce the appointment of Philip Sutton, Ph.D., as Vice President of Translational Sciences.

Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announced the completion of all three cohorts in their Phase I Single Ascending Dosing (SAD) clinical trial.

Replicate Bioscience , a company pioneering self-replicating RNA (srRNA) therapies for use against cancers, immune and inflammatory disorders, and other diseases, announced today that Zelanna Goldberg, M.D. , will join the company as Chief Medical Officer and Mohit Trikha , Ph.D., will join the company’s Board of Directors, effective immediately.

Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today the appointment of Stephen Griffin , Ph.D. to Chief Executive Officer, effective immediately.

Promotes Rebecca Bradford to Vice President, Government Programs and Linda Johnson to Vice President of Licensing and Intellectual Property.

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, today announced the initiation of the CANYON Phase 2 clinical trial evaluating EDG-5506 in individuals with BMD.

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the closing of a $12 million lead investment in the company’s Series D equity financing by Concord Innovation Fund II, LP.

Affini-T Therapeutics, Inc ., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, today announced the appointment of Jill DeSimone to its board of directors.

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today signed an exclusive distribution agreement in Greece for the CompuFlo ® Epidural System with F&M Feed, a leading provider of medical equipment, devices and consumables.

OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human papillomavirus (HPV) that can cause cancer.